US Corporate Board Director Changes SEC Filings — October 16, 2026

16-10-2026

Ironwood Pharmaceuticals' Board appointed Chief Commercial Officer Tammi Gaskins as Chief Executive Officer and a Board member, effective January 1, 2027, when Tom McCourt retires from the CEO role after 17 years at the company; McCourt will remain on the Board. The transition follows a turnaround year in which LINZESS was returned to blockbuster status and growth, though the release provides no specific financial figures for the period.

• · Gaskins led commercial development efforts for apraglutide, a once-weekly GLP-2 analog in Phase 3 for adults with short bowel syndrome with intestinal failure (SBS-IF)
• · LINZESS is described as the #1 prescribed brand in the U.S. for IBS-C or CIC, based on IQVIA data
• · McCourt led the acquisition of VectivBio, which brought apraglutide into Ironwood's late-stage pipeline
• · McCourt previously held commercial and drug development roles at Merck, Astra Merck, AstraZeneca, Novartis and Amgen
• · The company states it strengthened its balance sheet during 2026, though no figures are disclosed in this release

16-10-2026

Northann Corp. (NCL) disclosed in an 8-K that its Board of Directors elected Mr. Dat Nguyen as a director on October 12, 2026, to fill the vacancy created by the resignation of Mr. Lin Li. Mr. Nguyen was determined to be independent under NYSE American listing rules and financially literate, and will join the Audit, Nomination and Compensation Committees; the board returns to a full five members, including three independent directors.

• · Mr. Nguyen will serve on the Audit, Nomination and Compensation Committees
• · Mr. Nguyen previously led EY Indochina's Technology Advisory Practice (January to October 2017) and served as Country Director of Accenture Vietnam (August 2012 to September 2015)
• · Mr. Nguyen has been an angel investor and advisor to startups in AI, blockchain, and quantum-safe cybersecurity since 2018
• · Mr. Nguyen holds a B.A.Sc. in Engineering and a B.Sc. in Biology from the University of Ottawa and completed executive education at Harvard Kennedy School and MIT Sloan
• · No familial or other relationships with directors or management, and no Item 404(a) related-party transactions disclosed
• · Filing is signed by Bradley Lalonde, who serves as both Chairman and CEO, and is dated October 15, 2026

16-10-2026

REGENXBIO Inc. (RGNX) disclosed that director Kenneth T. Mills resigned from its Board of Directors effective October 21, 2026, to focus on his new role as CEO of another company, stating the departure was not related to any disagreement with the Company. The Board appointed George Migausky as Chairman, and Daniel Tassé stepped down as Lead Independent Director under the Corporate Governance Guidelines but remains on the Board.

• · Mills' resignation is effective October 21, 2026, and was announced October 14, 2026
• · The new Chairman is an independent director, which is the stated reason Tassé stepped down as Lead Independent Director under the Corporate Governance Guidelines

16-10-2026

Truist Financial announced executive leadership appointments to strengthen its leadership depth as it focuses on growing core deposits, deepening primary banking relationships, and investing in client capabilities. D. Steve Boland joins as vice chair, Shimna Sameer becomes chief consumer banking officer, and Jeff Warner joins as chief small business banking officer, all reporting to CEO Mike Lyons. Dontá Wilson, chief consumer and small business banking officer, is leaving the bank.

• · Boland retired from Bank of America in 2025, where he was chief administrative officer and previously president of Retail Banking
• · Jeff Dunn and Bryan Cram will act as interim co-heads of Truist Wealth, reporting to Kristin Lesher
• · Warner most recently served as head of small business at PNC
• · Sameer was previously announced to lead Truist Wealth before this role change
• · Boland, Sameer and Warner will each report directly to CEO Mike Lyons

16-10-2026

Emergent BioSolutions announced that CFO Richard S. Lindahl will retire effective December 31, 2026, with Frank Vargo, VP and Treasurer, becoming interim CFO effective January 1, 2027. Lindahl will serve as a senior executive advisor from January 1 through March 31, 2027 to support the transition. The announcement is framed as part of the company's ongoing multi-year transformation plan, and the filing contains no quantitative performance data.

• · Frank Vargo has been with Emergent since 2019 and is serving as interim CFO, not a permanent appointment
• · Lindahl joined Emergent in 2018 after prior CFO roles at CEB and treasurer roles at Sprint Nextel
• · Lindahl will remain on the board of Compass Therapeutics, Inc. and pursue board service and advisory work after retirement
• · Filing states no permanent CFO search timeline; the interim arrangement's duration is not specified

16-10-2026

Scotts Miracle-Gro disclosed that Christopher J. Hagedorn, its former Executive Vice President & Chief Strategy Officer, departed on September 30, 2026. Under a Separation Agreement dated October 13, 2026, he receives 24 months of salary, 12 months of outplacement support, 24 months of COBRA benefits offset, and a bonus amount equal to 2.0 times his target bonus payable in two installments. Unvested equity awards are largely forfeited, while 57,033 options vested in full and remain exercisable for 180 days, and 16,239 performance units remain eligible to vest in February 2027 subject to performance criteria.

• · Hagedorn is eligible for a fiscal 2026 incentive payout under the Executive Incentive Plan, payable November 2026, based on target bonus through the Termination Date multiplied by funded plan results and a discretionary personal performance factor
• · Separation payments are conditioned on Hagedorn not revoking acceptance of the agreement and, for bonus installments, on continued compliance with post-employment obligations
• · Restrictive covenants include noncompetition, confidentiality, cooperation and nonsolicitation, reinforced by a prior agreement dated August 30, 2024 that remains in effect
• · Hagedorn retains vested benefits under the company's retirement and retiree medical plans

16-10-2026

Fox Factory announced that CEO Mike Dennison is stepping down, with independent director Douglas Grimm appointed Interim CEO effective October 16, 2026, and a search for a permanent CEO launched via Heidrick & Struggles. The company also issued preliminary Q3 FY2026 results below expectations: net sales of $336M to $340M versus guidance of $355M to $380M, and adjusted EBITDA of $38M to $42M (excluding about $12M of IEEPA tariff refunds) versus guidance of $46M to $54M. FY2026 guidance was cut to net sales of $1.35B to $1.38B (from $1.42B to $1.47B) and adjusted EBITDA of $140M to $150M excluding tariff refunds (from $176M to $196M), with the Marucci Sports divestiture closed September 25, 2026 and supply disruption, input-cost inflation, and upfit operating challenges cited as drivers.

• · Q3 FY2026 Marucci Sports net sales (~$33M) fell short of the ~$46M assumed in guidance, and Marucci underperformed before its September 25, 2026 closing
• · Q3 underperformance was attributed to Marucci Sports, a Powered Vehicles Group supply disruption with higher operating costs and unfavorable mix, upfit challenges in Aftermarket Applications, and softer bike sales in Specialty Sports
• · Q4 FY2026 adjusted EBITDA outlook cites higher aluminum, steel and freight inflation and lower chassis availability, with segment margins for Powered Vehicles and Aftermarket Applications expected roughly flat year over year
• · Company states the majority of expected IEEPA tariff refunds has been received and the outlook assumes no additional refunds; the Board seeks a permanent CEO with Heidrick & Struggles, and Grimm is not a candidate
• · Complete Q3 results, including GAAP reconciliation, will be filed in the Form 10-Q and earnings call is scheduled for November 5, 2026; preliminary figures are unaudited and subject to change

16-10-2026

AT&T Inc. disclosed that Lori M. Lee, Global Marketing Officer & Senior Executive Vice President – International, will retire effective December 31, 2026, and her role will be eliminated following the company's agreement to sell its wireless business in Mexico and other reorganizational efforts. The filing contains no financial results, so no quantitative performance comparisons are reported, and the disclosure is primarily a leadership change tied to a divestiture.

• · Lori M. Lee's retirement is effective December 31, 2026, and the announcement was made October 14, 2026.
• · The Mexico wireless divestiture agreement was announced October 13, 2026, one day before the officer announcement.
• · The filing includes Item 9.01 with only a Cover Page Interactive Data File (Exhibit 104); no financial statements are attached.

16-10-2026

Copart's board granted CEO A. Jayson Adair a stand-alone nonstatutory stock option to purchase 20,000,000 shares, outside the 2007 Equity Incentive Plan and conditioned on stockholder approval at the 2026 Annual Meeting; if approval is not obtained, the option is forfeited. The option has four equal 5,000,000-share tranches at exercise prices of $26.27, $35.03, $43.78 and $52.54, a 10-year term, and vests on the 5th anniversary of the October 14, 2026 grant date, subject to continued service. Adair is expected to receive a $1 annual salary with no bonus or other equity awards during the 10-year period, other than approved perquisites.

• · Option granted outside the 2007 Equity Incentive Plan and forfeited entirely if stockholders do not approve at the 2026 Annual Meeting or a subsequent special meeting
• · Option vests only on the 5th anniversary of the grant date (October 14, 2031), subject to continued CEO service, with accelerated vesting on death or disability (based on 30-day average price exceeding exercise price) or on a change in control
• · Vested shares, and gains net of taxes on exercise, are subject to a service-based clawback of 10% per whole or partial year after CEO termination and a holding period through the 10-year term
• · Option is intended as the CEO's only substantive cash or equity compensation for 10 years, excluding approved perquisites
• · Option is subject to the Compensation Recovery Policy filed with the FY2026 10-K (fiscal year ended July 31, 2026)
• · Filing includes Exhibit 10.1 (the Option Agreement) and Inline XBRL cover page data

16-10-2026

WidePoint Corporation (NYSE American: WYY) disclosed that Chief Financial Officer Robert George tendered his resignation on October 9, 2026, effective upon filing of the Company's Form 10-Q for the quarter ended September 30, 2026. The resignation is attributed to personal and family reasons and is stated not to involve any disagreement with the Company. Mr. George will remain with the Company in a non-officer capacity to support an orderly transition.

• · Resignation effective upon filing of the Form 10-Q for the quarter ended September 30, 2026
• · Mr. George will continue assisting the Company in a non-officer capacity during the transition period
• · Filing states the resignation did not result from any disagreement with the Company

16-10-2026

Quantum Cyber N.V. (formerly MAINZ BIOMED N.V., ticker QUCY on Nasdaq Capital Market) disclosed in an 8-K dated October 16, 2026 that its board appointed Major General (Retired) Alberto C. Rosende as an independent director effective October 12, 2026, placing him on the Audit, Compensation, and Nomination Committees. The same day, director and Quantum Drones President Peter M. O'Rourke resigned from the board and his role, and his employment agreement (effective July 1, 2026) was terminated; the company states the resignation was not due to any disagreement with the company. The filing contains no financial figures.

• · Maj. Gen. (Ret.) Rosende serves as President and CEO of M2i Global Inc. since September 2024 and previously was its VP of Business Operations and Integration (March 2023 to August 2024)
• · Rosende was Commanding General of the 63rd Readiness Division covering seven southwestern states, and is a combat veteran of Afghanistan and Iraq
• · Board found Rosende independent under Nasdaq listing standards and financially literate for audit committee purposes
• · Rosende's director compensation follows the standard non-employee director program described in the June 1, 2026 DEF 14A proxy
• · Filing states no arrangements or understandings with any other person regarding Rosende's appointment and no related-party transaction interest under Item 404(a)
• · Filing is an emerging growth company under the 2026 cover page and the company name appears to have changed from MAINZ BIOMED N.V. (name change dated November 12, 2021 per EDGAR header)

16-10-2026

TOMI Environmental Solutions appointed Niroshan Srirathan, 39, its Interim Chief Financial Officer since May 16, 2026, as permanent CFO effective October 11, 2026. He previously served as the Company's Controller from May 4, 2026, and has UK public-company finance experience at Vistry Group plc and Berkeley Group Holdings plc. The filing discloses an annual base salary of $205,000 under an offer letter, with no material related-party transactions or family relationships reported.

• · Srirathan served as Senior Finance Manager (Regional Comptroller) at Vistry Group plc from April 2024 to January 2025 and as Finance Transformation Lead at Berkeley Group Holdings plc from May 2020 to February 2024
• · He qualified as a Chartered Accountant in 2012 and is pursuing U.S. CPA qualification in Maryland
• · The full offer letter will be filed as an exhibit to the Company's next periodic report rather than with this 8-K

16-10-2026

Ocular Therapeutix, Inc. (OCUL) disclosed that Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer, notified the Company on October 14, 2026 of his resignation, effective October 16, 2026, to become Chief Executive Officer of a privately-held company. The filing discloses no financial metrics, and it does not state a reason for the departure beyond the new role or name a successor.

• · Resignation notice dated October 14, 2026; effective date October 16, 2026
• · Departing officer is taking the CEO role at a privately-held company (name not disclosed)
• · No successor or interim Chief Strategy Officer is named in the filing

16-10-2026

Alliance Entertainment Holding Corp disclosed in an 8-K that its Compensation Committee authorized an increase in CFO Amanda Gnecco's annual base salary from $247,200 to $350,000, effective October 1, 2026. Her prorated target bonus for the fiscal year ending June 30, 2027 is set at $81,075. The filing reports a compensation change for an existing officer rather than a departure or new appointment.

• · The salary increase was authorized by the Compensation Committee of the Board of Directors on October 12, 2026
• · The bonus proration reflects a mid-year salary adjustment, with three months at the old salary rate and nine months at the new rate
• · Item 9.01 lists only the XBRL cover page interactive data file (Exhibit 104) with no other financial statements attached

16-10-2026

Bank of Marin Bancorp disclosed under Item 5.02 that Brandi Campbell, Executive Vice President and Head of Retail Banking at Bank of Marin, will leave the company effective October 16, 2026, by mutual agreement. Under a separation and release agreement, she is entitled to three months' pay as a lump sum (less applicable deductions) and nine months of COBRA premium reimbursement in exchange for a release of claims.

• · Separation is mutually agreed; no reason for departure is stated in the filing
• · Release of claims is required in exchange for severance, to the fullest extent permitted by law
• · Departing officer oversees the Head of Retail Banking function, a key customer-facing business line

16-10-2026

CalciMedica, Inc. (CALC) disclosed that Chief Financial Officer Stephen Bardin, who also serves as principal accounting officer and principal financial officer, resigned on October 15, 2026, to pursue another professional opportunity. The resignation takes effect immediately after the filing of the Company's Form 10-Q for the quarter ended September 30, 2026, and the company states it was not due to any disagreement with the Company.

• · Resignation notice provided October 15, 2026; effective immediately following filing of the Q3 2026 Form 10-Q (quarter ended September 30, 2026)
• · The 8-K states the resignation was not due to any disagreement with the Company
• · The CFO role also covers principal accounting officer duties, so the transition affects both financial and accounting leadership until a successor is named
• · The filing does not name a successor or interim CFO, and does not disclose any compensatory arrangements

16-10-2026

TScan Therapeutics, Inc. (Nasdaq: TCRX) disclosed that directors Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board and all committees effective October 13, 2026, with the company stating no disagreement over operations, practices, or policies. The Board filled the resulting Nominating and Corporate Governance Committee seats by appointing Stephen Biggar (member) and R. Keith Woods (chairperson), and reconstituted the Audit Committee to Katina Dorton, Barbara Klencke and R. Keith Woods.

• · Board resignations were effective the same day as the event (October 13, 2026) and the filing was made October 16, 2026
• · Resignations were explicitly not tied to any disagreement with the company
• · Stephen Biggar joins the Board's governance committee as a member; R. Keith Woods takes over as its chair

16-10-2026

Post Holdings disclosed that Senior Vice President and Chief Accounting Officer Bradly A. Harper is taking a temporary medical leave of absence, with CFO Matthew J. Mainer serving as Interim Chief Accounting Officer and principal accounting officer during the leave. The Board also approved an updated Code of Conduct on October 15, 2026, effective February 1, 2027, which modernizes the prior code without any waiver of its provisions. No financial metrics were disclosed in this filing.

• · The New Code covers emerging risk areas including artificial intelligence, prediction markets and fraud prevention
• · Expanded or restructured content addresses human rights, trade compliance, cybersecurity and data protection, workplace civility, records management, conflicts of interest and internal investigations
• · The Prior Code and New Code are posted on the company website under the Governance section of the Sustainability portion

16-10-2026

Waterstone Financial, Inc. (NASDAQ: WSBF) announced that director Derek L. Tyus has resigned from the Boards of the Company and WaterStone Bank, effective October 20, 2026, citing a new professional commitment and stating the resignation did not result from any disagreement with the company. Tyus had served since 2021 on the Company Board's Audit and Compensation Committees and the Bank Board's Executive Committee. The departure is governance-related and does not disclose any change in financial performance.

• · Tyus served on the Audit and Compensation Committees of the Company Board and the Executive Committee of the Bank Board
• · Resignation explicitly stated to be unrelated to any disagreement on operations, policies, or practices
• · Waterstone Mortgage Corporation is a wholly owned national lender licensed in 48 states

16-10-2026

Laser Photonics Corp (NASDAQ: LASE) announced that founder Dmitri Nikitin has been appointed Executive Chairman and principal executive officer, assuming responsibilities previously held by CEO Wayne Tupuola, who resigned for medical reasons effective October 13, 2026. The company does not intend to appoint a separate CEO, and interim President Ann Tewari returned to her prior role as Global Vice President, Operations and Strategy. The filing contains no quantitative financial results, so no period-over-period comparison is available.

• · Nikitin's stated priorities include advancing the LSAD platform, strengthening engineering, building a disciplined marketing and sales organization, and integrating prior acquisitions and product lines
• · Company is pursuing defense applications (anti-drone directed energy) and modernizing domestic manufacturing capacity for U.S. military
• · Tupuola resigned due to medical reasons, a leadership transition with no separate CEO planned, concentrating executive authority in a single founder-led role

16-10-2026

Costco's Compensation Committee approved fiscal 2027 executive bonus criteria on October 13, 2026, with the Nominating and Governance Committee approving environmental and social performance criteria. Non-CEO executive officers are eligible for base bonuses of $400,000 (split $160,000 sales, $160,000 pre-tax income, and up to $80,000 for environmental and social objectives), while the CEO's base bonus is $1.2 million (split $500,000 sales, $500,000 pre-tax income, and up to $200,000 for environmental and social metrics). The filing discloses no officer departure or appointment, so the preliminary 'Officer Change' classification appears inaccurate.

• · Bonus structure allows payouts from zero up to 120% of target for each sales and pre-tax income goal
• · Environmental and social criteria include human capital and environmental-related quantitative metrics
• · The full Fiscal 2027 Executive Bonus Plan is filed as Exhibit 10.1
• · No director or officer departure, election, or appointment is reported in this filing

16-10-2026

Feel The World, Inc. (d/b/a XERO Shoes) disclosed that Chief Financial Officer Heidi Huntington resigned effective October 16, 2026, to pursue other professional opportunities, with no disagreement with the company cited. The board appointed Zachary Guzy as CFO effective upon her resignation, at an annual base salary of $290,000 plus eligibility for the annual bonus and equity compensation plans.

• · Huntington's resignation notice was given September 21, 2026, roughly three weeks before its October 16, 2026 effective date
• · Guzy previously served as CFO of Enthusiast Auto Holdings, a private-equity-backed e-commerce company, and as CFO and COO of mDesign Global
• · The filing states Huntington's departure was not the result of any disagreement with the company on operations, policies, or practices

16-10-2026

Silver Bow Mining Corp. amended the vesting milestones on 200,000 performance warrants held by CEO C. Travis Naugle, replacing a preliminary economic assessment (PEA) milestone with milestones tied to its acquisition of the Jefferson County Metallurgical Complex and a term sheet with Ocean Partners UK Limited for approximately $88M in funding and offtake arrangements. The Board also approved a new grant of 2,000,000 performance warrants to Naugle, vesting on resource, market capitalization, and production milestones, both subject to NYSE American and shareholder approval. The filing is mixed for shareholders: it reflects a stronger acquisition and funding pipeline, but it adds material dilution tied to a CEO compensation package whose milestones have yet to be met.

• · The 200,000 warrants tied to the original PEA milestone are now tied to the Jefferson County acquisition closing and the Ocean Partners term sheet, which the Board deemed achieved as of October 2, 2026, pending NYSE American approval.
• · Shares underlying the New Performance Warrants may not be issued before shareholder approval; the Grant Date is set by that approval.
• · Exercise prices for New Performance Warrants reset upward to the current market price on the Grant Date if that price exceeds $12.00 (tranches i-iv) or $18.00 (production tranche), so holders receive no discount if the stock has risen.
• · Vesting on the two market capitalization tranches requires 30 consecutive trading days at or above $500M and $1B, respectively, before the fifth anniversary of the Grant Date.
• · The production tranche requires underground ore from the Rainbow Block to be processed and delivered at specified rates, with no single stoppage exceeding 10 consecutive days.
• · Warrants were issued under Section 4(a)(2) of the Securities Act, as disclosed under Item 3.02, a private placement exemption.
• · The Company is an emerging growth company, and its common shares trade on NYSE American under the symbol SBMT.

16-10-2026

Farmhouse, Inc. (OTC: FMHS) appointed Kevin Asher as Chief Financial Officer, principal financial officer and principal accounting officer, effective October 12, 2026, reversing his prior tenure as CFO. Former CFO Lanny R. Lang moved to the non-officer role of Senior Director of Financial Reporting, retaining responsibility for financial statements, SEC filings coordination and governance support. The company frames the change as adding financial capacity while dividing responsibilities between capital markets/investor relations (Asher) and financial reporting (Lang).

• · Lang's CFO-to-non-officer transition means the company's principal financial officer role changed hands while Lang retains reporting duties, which investors may want to monitor for governance clarity
• · Asher's responsibilities include capital markets, investor relations, financing activity and financial oversight, signaling potential future capital raises tied to the treasury strategy
• · Company describes a majority-Bitcoin treasury complemented by gold, held via Farmhouse Treasury LLC with institutional custody
• · Forward-looking risks cited include financing availability, Bitcoin and gold price volatility, custody and cybersecurity risks, and dilution from future financing

16-10-2026

VerifyMe, Inc. (VRME) filed an 8-K under Items 5.02, 5.03, 5.07, and 9.01 reporting a director or officer departure or election, an amendment to its articles of incorporation, and the results of a shareholder vote. The filed exhibit (EX-3.1) is the Form of Amended and Restated Articles of Incorporation for OpenWorld, Inc., which authorizes 1,250,000,000 total shares across Common Stock (675,000,000), Blockchain Common Stock (500,000,000), and Preferred Stock (75,000,000), all at $0.001 par value. The excerpt provided does not include the officer/director details or vote tallies from Items 5.02 and 5.07, so the specific personnel change cannot be identified from the text supplied.

• · Filing includes Item 5.03, indicating an amendment to articles of incorporation or bylaws, with the exhibit naming OpenWorld, Inc. as the corporate name, which may reflect a name change or a filing-entity naming discrepancy to verify
• · Existing Series A Convertible Preferred Stock (designated May 18, 2007, amended February 1, 2013) and Series B Convertible Preferred Stock (designated June 18, 2025) carry over under the amended articles
• · Board of directors may range from 1 to 15 members; the board may issue new Preferred or Blockchain Common Stock series without shareholder consent unless the certificate of designation provides otherwise
• · Director and officer liability is eliminated or limited to the fullest extent permitted under Nevada Revised Statutes, and expense advancement for defense is mandated

16-10-2026

GBank Financial Holdings Inc. (GBFH) disclosed that Olivia M. Caley, Senior Vice President, Financial Reporting Director and interim principal financial officer and principal accounting officer, resigned effective October 13, 2026. The Board has designated Jeffrey Newgard, President and CEO of the Bank, as interim principal financial officer and Christine Nelson, SVP and Controller of the Bank, as interim principal accounting officer, while it continues to search for a permanent CFO.

• · Caley's resignation was signed October 12, 2026 and took effect October 13, 2026
• · Newgard was appointed President and CEO of the Bank May 15, 2026, effective June 8, 2026, and previously led Bank of Idaho from July 2015
• · Nelson joined the Bank as Vice President and Director of Accounting in September 2022 and became SVP and Controller in April 2025
• · Neither interim designee has a family relationship with directors or executive officers, nor a material interest in a related-party transaction under Item 404(a)
• · Filing includes Inline XBRL cover page (Exhibit 104)

16-10-2026

LifeStance Health Group, Inc. disclosed that Teresa DeLuca, M.D., notified the Board of Directors on October 14, 2026 of her resignation from the Board and all of its committees, effective December 31, 2026. The filing states the resignation is not the result of any disagreement with the Company. No financial performance data is included in this filing.

• · Resignation effective December 31, 2026, with notice given October 14, 2026
• · Dr. DeLuca resigns from all Board committees as well as the Board itself
• · Filing explicitly states no disagreement with the Company led to the resignation
• · Company trades on the Nasdaq Global Select Market under the symbol LFST

16-10-2026

Titan International, Inc. (TWI) entered into a deferred compensation arrangement with CEO Paul G. Reitz, awarding him $2.3 million in deferred compensation payable starting in 2030 under a rabbi trust structure. The Company will fund the trust with approximately 332,370 shares of common stock valued at about $2.3 million, and the trust assets remain subject to general creditors in insolvency. The filing is a compensation-related disclosure rather than an officer departure or election, and it contains no operating performance metrics.

• · Payment of the deferred compensation will not commence until 2030 and may be taken as a lump sum or installments at Mr. Reitz's election
• · Plan and Trust Agreement were approved by the Compensation Committee and Board on October 12, 2026
• · Mr. Reitz holds no preferred claim or beneficial ownership in trust assets; his rights are unsecured contractual rights; trustee exercises voting rights
• · Company remains obligated to pay any shortfall if trust assets are insufficient

16-10-2026

AutoNation, Inc. (NYSE: AN) announced on October 16, 2026 the appointment of Mark Stewart to its Board of Directors as an independent director. Stewart currently serves as CEO and President of The Goodyear Tire & Rubber Company, a role he has held since January 2024, and previously led North American operations at Stellantis. The filing is a board appointment announcement and contains no financial results, so no period-over-period performance metrics are reported.

• · Stewart was appointed as an independent director, which the company frames as strengthening the Board's strategic perspective and operational discipline.
• · Stewart previously held senior roles at Amazon (VP, Customer Fulfillment), ZF TRW Automotive, TRW, and Tower Automotive.
• · Stewart holds a bachelor's degree in electrical and electronics engineering from Vanderbilt University and an MBA from the University of Tennessee, Knoxville.
• · Stewart is a member of Business Roundtable and previously served on the Board of the Auto Alliance.

16-10-2026

MiniMed (Nasdaq: MMED) announced the completion of its separation from Medtronic plc, marking its first day as a fully independent company. Medtronic accepted 55,032,401 Medtronic ordinary shares in exchange for 252,813,348 shares of MiniMed common stock, leaving Medtronic with no remaining equity stake in MiniMed. The exchange offer was 5.4x subscribed, and CEO Que Dallara framed the milestone as the start of a new era of independent decision-making in diabetes care.

• · Newly issued MiniMed shares are credited in book-entry form to tendering shareholders' accounts; fractional shares are aggregated and sold in the open market with cash checks issued afterward.
• · The full exchange offer results were disclosed separately by Medtronic in a press release issued the prior day (October 15, 2026).

16-10-2026

Odyssey Marine Exploration (NASDAQ: OMEX) announced that the SEC declared its Form S-4 registration statement effective on October 15, 2026, for the proposed merger with American Ocean Minerals Corporation (AOMC), with a special stockholder meeting set for December 2, 2026. The company also announced a 1-for-25 reverse stock split effective October 28, 2026, reducing outstanding common stock from approximately 58.6 million to approximately 2.3 million shares, with trading on a split-adjusted basis beginning October 29, 2026. Completion of the reverse split is a condition for certain investors to provide merger financing, and stockholder approval of the merger is still required.

• · Reverse split reduces outstanding shares by roughly 96% while the company is seeking to raise its share price; fractional shares will be paid out in cash.
• · Post-merger, Odyssey is expected to be renamed American Ocean Minerals Corporation and trade under the symbol AOMC.
• · Reverse split was approved by stockholders on June 1, 2026, with the ratio set by the Board on June 15, 2026; it is not subject to the December special meeting vote.
• · Merger completion remains subject to stockholder approval and other closing conditions; the filing contains forward-looking risk disclosures including litigation, financing and mineral extraction risks.

16-10-2026

Union Pacific announced that Executive Vice President and Chief Financial Officer Jennifer Hamann will retire in early 2027 after a 35-year career that began in 1992 with the company's audit staff. The company will announce succession plans at a later date. CEO Jim Vena praised her leadership through historic challenges, and Hamann stated she remains an ardent supporter of the pending merger that would make Union Pacific the nation's first transcontinental railroad.

• · Hamann joined Union Pacific in 1992 on the audit staff and later served in Finance, Human Resources, Marketing and Sales, Investor Relations and Corporate Audit before becoming CFO in January 2020
• · Hamann was the first woman to serve as Union Pacific's CFO and received a Women MAKE Award
• · Hamann served on boards of TTX Company, Grupo Ferroviario Mexicano and Steel Dynamics

16-10-2026

Change Agents Corporation (formerly Avalon GloboCare Corp., Nasdaq: CHGA) appointed Eric Weisblum as an independent director effective October 12, 2026, disclosed in an 8-K filed October 16, 2026. Mr. Weisblum will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees. The filing discloses no financial results, compensation terms, or quantitative figures.

• · Mr. Weisblum has been CEO of Silo Pharma Inc. (a biopharmaceutical company he founded) since 2020.
• · Prior to Silo Pharma, he held the Series 7, Series 55, and Series 63 securities registrations while at Domestic Securities, and from 1993 to 2002 structured financing transactions at M.H. Meyerson & Co. Inc.
• · The Company states it has no arrangement with Mr. Weisblum for his selection and he is not related to any director or executive officer; no Item 404(a) related-person transactions were identified.
• · The filing text refers to the director as 'Mr. Weinblum' in one place, a spelling inconsistency with 'Weisblum' elsewhere in the document.

16-10-2026

Erasca, Inc. (ERAS) disclosed on October 15, 2026 that it is realigning leadership responsibilities to support the development and potential commercialization of its RAS-targeting programs. Responsibilities overseen by Chief Operating Officer Nicholas (Nik) Chetwyn, Ph.D. are being transferred to other leadership team members to streamline the reporting structure, and his employment will terminate effective November 2, 2026. The filing contains no financial results, dollar amounts, or quantitative performance data.

• · Chetwyn's employment terminates effective November 2, 2026
• · Filing states the departure is part of a reporting-structure streamlining rather than a disclosed performance or disagreement issue